ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve the Standalone and Consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ANG Lifesciences India Ltd has informed BSE that its Board of Directors will meet on Thursday, 14 August 2025 at 5:00 PM at the registered office in Amritsar. The main agenda is to consider and approve the Standalone and Consolidated Un-Audited Financial Results for the quarter ended 30 June 2025 (Q1 FY26). The trading window for insiders is already closed since 1 July 2025 and will reopen 48 hours after the results are publicly announced. Any other business with the Chairman's permission may also be taken up. No actual financial numbers have been disclosed in this filing — it is only an advance notice of the board meeting.
This is a routine regulatory intimation and not a results announcement itself. Shareholders should watch the results on or after 14 August 2025 for actual Q1 performance. Stock movement may occur on results day; insiders cannot trade until 48 hours post-announcement.